États-Unis Pharmaceuticals

Idenix Pharmaceuticals LLC (IDIX)

Suivre

Code mnémonique : IDIX Marché : NSQ
Préparation du graphique...
Télécharger le graphique Copier l’image du graphique Copier le lien Partager sur 𝕏 Prix


• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Signal d'achat Signal de vente Résultats financiers
Aucun signal d’activité d’initié détecté

Les transactions d’initiés n’ont pas déclenché de signaux d’activité inhabituelle pour cette société.

Meilleurs initiés
Transactions
Abréviations B : Achat, S : Vente, PP : Achat planifié, PlS : Vente planifiée, PrS : Vente proposée, O : Option / Autre
BAUPOST GROUP LLC/MA Actionnaire important
Date de transaction
Achat
Prix
315,16
Quantity 6 617 -6.9%
Valeur 4 485 967 $US
Fanning Paul SVP, Human Resources Dirigeant
Date de transaction
Vente
Prix
316,14
Quantity 27 950 +40.0%
Valeur 3 604 616 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
104,09
Quantity 95 903 +21.7%
Valeur 1 386 527 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
6,52
Quantity 493 +0.0%
Valeur 3 214 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,80
Quantity 436 +0.0%
Valeur 2 529 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,79
Quantity 883 +0.0%
Valeur 5 113 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,46
Quantity 7 402 +0.0%
Valeur 40 415 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,11
Quantity 11 433 +0.0%
Valeur 58 423 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,10
Quantity 39 +0.0%
Valeur 199 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,79
Quantity 3 093 +0.0%
Valeur 11 722 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,17
Quantity 4 336 +0.0%
Valeur 13 745 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,04
Quantity 232 +0.0%
Valeur 705 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,97
Quantity 427 +0.0%
Valeur 1 268 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,96
Quantity 8 960 +0.0%
Valeur 26 522 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,90
Quantity 3 117 +0.0%
Valeur 9 039 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,85
Quantity 1 321 +0.0%
Valeur 3 765 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,78
Quantity 997 +0.0%
Valeur 2 772 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,69
Quantity 997 +0.0%
Valeur 2 682 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,56
Quantity 2 493 +0.0%
Valeur 6 382 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,47
Quantity 366 +0.0%
Valeur 904 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 35 735 +0.1%
Valeur 86 121 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,46
Quantity 9 197 +0.0%
Valeur 50 216 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,11
Quantity 2 107 +0.0%
Valeur 10 767 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
4,70
Quantity 20 228 +0.1%
Valeur 95 072 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,79
Quantity 140 +0.0%
Valeur 531 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,17
Quantity 1 146 +0.0%
Valeur 3 633 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,95
Quantity 6 476 +0.0%
Valeur 19 104 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 11 236 +0.0%
Valeur 27 079 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,80
Quantity 1 785 714 +5.7%
Valeur 4 999 999 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,11
Quantity 206 +0.0%
Valeur 1 053 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,88
Quantity 1 760 +0.0%
Valeur 6 829 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,79
Quantity 860 +0.0%
Valeur 3 259 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,96
Quantity 897 +0.0%
Valeur 2 655 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 17 270 +0.1%
Valeur 41 621 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,46
Quantity 486 +0.0%
Valeur 2 654 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
5,11
Quantity 1 332 +0.0%
Valeur 6 807 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,79
Quantity 165 +0.0%
Valeur 625 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,96
Quantity 44 +0.0%
Valeur 130 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,64
Quantity 822 +0.0%
Valeur 2 170 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 14 234 +0.0%
Valeur 34 304 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,79
Quantity 813 +0.0%
Valeur 3 081 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
3,04
Quantity 91 +0.0%
Valeur 277 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,96
Quantity 262 +0.0%
Valeur 776 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 36 048 +0.1%
Valeur 86 876 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 1 351 +0.0%
Valeur 3 256 $US
NOVARTIS AG Indirect 10% Owner
Date de transaction
Achat
Prix
2,41
Quantity 1 872 +0.0%
Valeur 4 512 $US
HODGSON THOMAS R Administrateur non-exécutif
Date de transaction
Achat
Prix
2,12
Quantity 10 387 +22.2%
Valeur 22 020 $US
HODGSON THOMAS R Administrateur non-exécutif
Date de transaction
Achat
Prix
2,15
Quantity 15 000 +47.2%
Valeur 32 250 $US
HODGSON THOMAS R Administrateur non-exécutif
Date de transaction
Achat
Prix
2,12
Quantity 11 000 +52.9%
Valeur 23 320 $US
HODGSON THOMAS R Administrateur non-exécutif
Date de transaction
Achat
Prix
2,08
Quantity 8 613 +70.6%
Valeur 17 915 $US
HODGSON THOMAS R Administrateur non-exécutif
Date de transaction
Achat
Prix
2,05
Quantity 5 000 +69.4%
Valeur 10 250 $US
Weidenbruch John Ex. VP, Gen. Counsel and Secr. Dirigeant
Date de transaction
Achat
Prix
1,89
Quantity 20 000 +133.3%
Valeur 37 800 $US
NOVARTIS AG INDIRECT 10% OWNER
Date de transaction
Achat
Prix
2,41
Quantity 3 431 +0.0%
Valeur 8 269 $US
NOVARTIS AG INDIRECT 10% OWNER
Date de transaction
Achat
Prix
2,62
Quantity 2 451 +0.0%
Valeur 6 422 $US
NOVARTIS AG Indirect 10% owner
Date de transaction
Achat
Prix
2,41
Quantity 5 444 +0.0%
Valeur 13 120 $US
NOVARTIS AG INDIRECT 10% OWNER
Date de transaction
Achat
Prix
4,05
Quantity 4 747 +0.0%
Valeur 19 225 $US
NOVARTIS AG Actionnaire important
Date de transaction
Achat
Prix
2,93
Quantity 4 654 +0.0%
Valeur 13 636 $US
NOVARTIS AG Actionnaire important
Date de transaction
Achat
Prix
2,41
Quantity 924 +0.0%
Valeur 2 227 $US
Mayers Douglas L EVP and Chief Medical Officer Dirigeant
Date de transaction
Achat
Prix
4,45
Quantity 30 000 +inf%
Valeur 133 500 $US
Koppy Susan Sr. VP, Business and Corp Dev. Dirigeant
Date de transaction
Achat
Prix
3,84
Quantity 400 +160.0%
Valeur 1 536 $US
NOVARTIS AG Actionnaire important
Date de transaction
Achat
Prix
20,48
Quantity 365 +0.0%
Valeur 7 475 $US
Sommadossi Jean-Pierre President, CEO, Chairman Administrateur exécutif
Date de transaction
Achat
Prix
9,13
Quantity 10 000 +0.5%
Valeur 91 300 $US
Koppy Susan Sr. VP, Business and Corp Dev. Dirigeant
Date de transaction
Achat
Prix
9,26
Quantity 200 +400.0%
Valeur 1 852 $US
NOVARTIS AG Actionnaire important
Date de transaction
Achat
Prix
16,23
Quantity 2 938 +0.0%
Valeur 47 684 $US
Pollard-Knight Denise Administrateur non-exécutif
Date de transaction
Vente
Prix
20,61
Quantity 629 498 -67.6%
Valeur 12 973 954 $US
NOVARTIS AG Actionnaire important
Date de transaction
Achat
Prix
20,61
Quantity 3 939 131 +14.4%
Valeur 81 185 490 $US
HODGSON THOMAS R
Date de transaction
Achat
Prix
14,00
Quantity 7 200 +20.5%
Valeur 100 800 $US
Corcoran Andrea Exec. VP, Legal and Admin.
Date de transaction
Achat
Prix
14,00
Quantity 7 200 +12.8%
Valeur 100 800 $US
3,7
Sommadossi Jean-Pierre President, CEO, Chairman Administrateur exécutif
Date de transaction
Achat
Prix
14,00
Quantity 6 364 +0.3%
Valeur 89 096 $US
3,2
Macdonald Guy Executive VP, Operations
Date de transaction
Achat
Prix
14,00
Quantity 10 000 +inf%
Valeur 140 000 $US
1,4
Arkowitz David Chief Financial Officer
Date de transaction
Achat
Prix
14,00
Quantity 8 000 +inf%
Valeur 112 000 $US
3,0
BARSHEFSKY CHARLENE
Date de transaction
Achat
Prix
14,00
Quantity 20 000 +inf%
Valeur 280 000 $US
CRAMB CHARLES W JR
Date de transaction
Achat
Prix
14,00
Quantity 7 200 +inf%
Valeur 100 800 $US
Egan James Sr. VP, Business and Corp Dev
Date de transaction
Achat
Prix
14,00
Quantity 13 400 +6.2%
Valeur 187 600 $US
3,1
GADICKE ANSBERT Actionnaire important
Date de transaction
Vente
Prix
14,00
Quantity 508 371 -9.6%
Valeur 7 117 194 $US
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2014-02-04 2014-01-31 A Achat BAUPOST GROUP LLC/MA Actionnaire important
6 617 -6.9%
315,16
4 485 967 $US 		6 617 -6.9% 315,16 4 485 967 $US
2012-03-20 2012-03-16 V Vente Fanning Paul

SVP, Human Resources

Dirigeant
27 950 +40.0%
316,14
3 604 616 $US 		27 950 +40.0% 316,14 3 604 616 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
95 903 +21.7%
104,09
1 386 527 $US 		95 903 +21.7% 104,09 1 386 527 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
493 +0.0%
6,52
3 214 $US 		493 +0.0% 6,52 3 214 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
436 +0.0%
5,80
2 529 $US 		436 +0.0% 5,80 2 529 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
883 +0.0%
5,79
5 113 $US 		883 +0.0% 5,79 5 113 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
7 402 +0.0%
5,46
40 415 $US 		7 402 +0.0% 5,46 40 415 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
11 433 +0.0%
5,11
58 423 $US 		11 433 +0.0% 5,11 58 423 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
39 +0.0%
5,10
199 $US 		39 +0.0% 5,10 199 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
3 093 +0.0%
3,79
11 722 $US 		3 093 +0.0% 3,79 11 722 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
4 336 +0.0%
3,17
13 745 $US 		4 336 +0.0% 3,17 13 745 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
232 +0.0%
3,04
705 $US 		232 +0.0% 3,04 705 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
427 +0.0%
2,97
1 268 $US 		427 +0.0% 2,97 1 268 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
8 960 +0.0%
2,96
26 522 $US 		8 960 +0.0% 2,96 26 522 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
3 117 +0.0%
2,90
9 039 $US 		3 117 +0.0% 2,90 9 039 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
1 321 +0.0%
2,85
3 765 $US 		1 321 +0.0% 2,85 3 765 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2,78
2 772 $US 		997 +0.0% 2,78 2 772 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2,69
2 682 $US 		997 +0.0% 2,69 2 682 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
2 493 +0.0%
2,56
6 382 $US 		2 493 +0.0% 2,56 6 382 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
366 +0.0%
2,47
904 $US 		366 +0.0% 2,47 904 $US
2012-02-23 2012-02-23 A Achat NOVARTIS AG

Indirect 10% Owner
35 735 +0.1%
2,41
86 121 $US 		35 735 +0.1% 2,41 86 121 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
9 197 +0.0%
5,46
50 216 $US 		9 197 +0.0% 5,46 50 216 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
2 107 +0.0%
5,11
10 767 $US 		2 107 +0.0% 5,11 10 767 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
20 228 +0.1%
4,70
95 072 $US 		20 228 +0.1% 4,70 95 072 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
140 +0.0%
3,79
531 $US 		140 +0.0% 3,79 531 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
1 146 +0.0%
3,17
3 633 $US 		1 146 +0.0% 3,17 3 633 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
6 476 +0.0%
2,95
19 104 $US 		6 476 +0.0% 2,95 19 104 $US
2011-11-22 2011-11-22 A Achat NOVARTIS AG

Indirect 10% Owner
11 236 +0.0%
2,41
27 079 $US 		11 236 +0.0% 2,41 27 079 $US
2011-04-13 2011-04-13 A Achat NOVARTIS AG

Indirect 10% Owner
1 785 714 +5.7%
2,80
4 999 999 $US 		1 785 714 +5.7% 2,80 4 999 999 $US
2011-02-25 2011-02-25 A Achat NOVARTIS AG

Indirect 10% Owner
206 +0.0%
5,11
1 053 $US 		206 +0.0% 5,11 1 053 $US
2011-02-25 2011-02-25 A Achat NOVARTIS AG

Indirect 10% Owner
1 760 +0.0%
3,88
6 829 $US 		1 760 +0.0% 3,88 6 829 $US
2011-02-25 2011-02-25 A Achat NOVARTIS AG

Indirect 10% Owner
860 +0.0%
3,79
3 259 $US 		860 +0.0% 3,79 3 259 $US
2011-02-25 2011-02-25 A Achat NOVARTIS AG

Indirect 10% Owner
897 +0.0%
2,96
2 655 $US 		897 +0.0% 2,96 2 655 $US
2011-02-25 2011-02-25 A Achat NOVARTIS AG

Indirect 10% Owner
17 270 +0.1%
2,41
41 621 $US 		17 270 +0.1% 2,41 41 621 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
486 +0.0%
5,46
2 654 $US 		486 +0.0% 5,46 2 654 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
1 332 +0.0%
5,11
6 807 $US 		1 332 +0.0% 5,11 6 807 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
165 +0.0%
3,79
625 $US 		165 +0.0% 3,79 625 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
44 +0.0%
2,96
130 $US 		44 +0.0% 2,96 130 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
822 +0.0%
2,64
2 170 $US 		822 +0.0% 2,64 2 170 $US
2010-11-26 2010-11-26 A Achat NOVARTIS AG

Indirect 10% Owner
14 234 +0.0%
2,41
34 304 $US 		14 234 +0.0% 2,41 34 304 $US
2010-08-23 2010-08-23 A Achat NOVARTIS AG

Indirect 10% Owner
813 +0.0%
3,79
3 081 $US 		813 +0.0% 3,79 3 081 $US
2010-08-23 2010-08-23 A Achat NOVARTIS AG

Indirect 10% Owner
91 +0.0%
3,04
277 $US 		91 +0.0% 3,04 277 $US
2010-08-23 2010-08-23 A Achat NOVARTIS AG

Indirect 10% Owner
262 +0.0%
2,96
776 $US 		262 +0.0% 2,96 776 $US
2010-08-23 2010-08-23 A Achat NOVARTIS AG

Indirect 10% Owner
36 048 +0.1%
2,41
86 876 $US 		36 048 +0.1% 2,41 86 876 $US
2010-06-08 2010-06-08 A Achat NOVARTIS AG

Indirect 10% Owner
1 351 +0.0%
2,41
3 256 $US 		1 351 +0.0% 2,41 3 256 $US
2010-02-26 2010-02-26 A Achat NOVARTIS AG

Indirect 10% Owner
1 872 +0.0%
2,41
4 512 $US 		1 872 +0.0% 2,41 4 512 $US
2009-12-17 2009-12-16 A Achat HODGSON THOMAS R Administrateur non-exécutif
10 387 +22.2%
2,12
22 020 $US 		10 387 +22.2% 2,12 22 020 $US
2009-12-17 2009-12-15 A Achat HODGSON THOMAS R Administrateur non-exécutif
15 000 +47.2%
2,15
32 250 $US 		15 000 +47.2% 2,15 32 250 $US
2009-12-14 2009-12-14 A Achat HODGSON THOMAS R Administrateur non-exécutif
11 000 +52.9%
2,12
23 320 $US 		11 000 +52.9% 2,12 23 320 $US
2009-12-14 2009-12-11 A Achat HODGSON THOMAS R Administrateur non-exécutif
8 613 +70.6%
2,08
17 915 $US 		8 613 +70.6% 2,08 17 915 $US
2009-12-14 2009-12-10 A Achat HODGSON THOMAS R Administrateur non-exécutif
5 000 +69.4%
2,05
10 250 $US 		5 000 +69.4% 2,05 10 250 $US
2009-11-24 2009-11-24 A Achat Weidenbruch John

Ex. VP, Gen. Counsel and Secr.

Dirigeant
20 000 +133.3%
1,89
37 800 $US 		20 000 +133.3% 1,89 37 800 $US
2009-08-24 2009-08-21 A Achat NOVARTIS AG

INDIRECT 10% OWNER
3 431 +0.0%
2,41
8 269 $US 		3 431 +0.0% 2,41 8 269 $US
2009-05-29 2009-05-29 A Achat NOVARTIS AG

INDIRECT 10% OWNER
2 451 +0.0%
2,62
6 422 $US 		2 451 +0.0% 2,62 6 422 $US
2009-02-23 2009-02-23 A Achat NOVARTIS AG

Indirect 10% owner
5 444 +0.0%
2,41
13 120 $US 		5 444 +0.0% 2,41 13 120 $US
2008-11-25 2008-11-19 A Achat NOVARTIS AG

INDIRECT 10% OWNER
4 747 +0.0%
4,05
19 225 $US 		4 747 +0.0% 4,05 19 225 $US
2008-09-03 2008-09-02 A Achat NOVARTIS AG Actionnaire important
4 654 +0.0%
2,93
13 636 $US 		4 654 +0.0% 2,93 13 636 $US
2008-05-30 2008-05-29 A Achat NOVARTIS AG Actionnaire important
924 +0.0%
2,41
2 227 $US 		924 +0.0% 2,41 2 227 $US
2008-03-13 2008-03-11 A Achat Mayers Douglas L

EVP and Chief Medical Officer

Dirigeant
30 000 +inf%
4,45
133 500 $US 		30 000 +inf% 4,45 133 500 $US
2007-07-19 2007-07-13 A Achat Koppy Susan

Sr. VP, Business and Corp Dev.

Dirigeant
400 +160.0%
3,84
1 536 $US 		400 +160.0% 3,84 1 536 $US
2006-06-08 2006-06-06 A Achat NOVARTIS AG Actionnaire important
365 +0.0%
20,48
7 475 $US 		365 +0.0% 20,48 7 475 $US
2006-05-11 2006-05-09 A Achat Sommadossi Jean-Pierre

President, CEO, Chairman

Administrateur exécutif
10 000 +0.5%
9,13
91 300 $US 		10 000 +0.5% 9,13 91 300 $US
2006-05-10 2006-05-08 A Achat Koppy Susan

Sr. VP, Business and Corp Dev.

Dirigeant
200 +400.0%
9,26
1 852 $US 		200 +400.0% 9,26 1 852 $US
2006-04-06 2006-04-04 A Achat NOVARTIS AG Actionnaire important
2 938 +0.0%
16,23
47 684 $US 		2 938 +0.0% 16,23 47 684 $US
2005-11-16 2005-11-14 V Vente Pollard-Knight Denise Administrateur non-exécutif
629 498 -67.6%
20,61
12 973 954 $US 		629 498 -67.6% 20,61 12 973 954 $US
2005-11-02 2005-10-31 A Achat NOVARTIS AG Actionnaire important
3 939 131 +14.4%
20,61
81 185 490 $US 		3 939 131 +14.4% 20,61 81 185 490 $US
2004-07-29 2004-07-27 A Achat
HODGSON THOMAS R
7 200 +20.5%
14,00
100 800 $US 		7 200 +20.5% 14,00 100 800 $US
2004-07-29 2004-07-27 A Achat
Corcoran Andrea

Exec. VP, Legal and Admin.
7 200 +12.8%
14,00
100 800 $US 		7 200 +12.8% 14,00 100 800 $US
2004-07-29 2004-07-27 A Achat
3,7
Sommadossi Jean-Pierre

President, CEO, Chairman

Administrateur exécutif
6 364 +0.3%
14,00
89 096 $US 		6 364 +0.3% 14,00 89 096 $US
2004-07-29 2004-07-27 A Achat
3,2
Macdonald Guy

Executive VP, Operations
10 000 +inf%
14,00
140 000 $US 		10 000 +inf% 14,00 140 000 $US
2004-07-29 2004-07-27 A Achat
1,4
Arkowitz David

Chief Financial Officer
8 000 +inf%
14,00
112 000 $US 		8 000 +inf% 14,00 112 000 $US
2004-07-29 2004-07-27 A Achat
3,0
BARSHEFSKY CHARLENE
20 000 +inf%
14,00
280 000 $US 		20 000 +inf% 14,00 280 000 $US
2004-07-29 2004-07-27 A Achat
CRAMB CHARLES W JR
7 200 +inf%
14,00
100 800 $US 		7 200 +inf% 14,00 100 800 $US
2004-07-29 2004-07-27 A Achat
Egan James

Sr. VP, Business and Corp Dev
13 400 +6.2%
14,00
187 600 $US 		13 400 +6.2% 14,00 187 600 $US
2004-07-28 2004-07-27 V Vente
3,1
GADICKE ANSBERT
Actionnaire important
508 371 -9.6%
14,00
7 117 194 $US 		508 371 -9.6% 14,00 7 117 194 $US
Explorer davantage

Plus de recherches sur les transactions d'initiés autour de Idenix Pharmaceuticals LLC

Plus de transactions d’initiés dans États-Unis
Sociétés similaires du secteur Healthcare avec une activité des initiés
Plus de sociétés Pharmaceuticals & Medical Research avec une activité d’initié
Plus de sociétés Pharmaceuticals avec une activité d'initiés
Opérations d'initiés en Amérique du Nord